Base editing (1) Biomarkers (1) Broad (1) CRISPR (3) CRISPR-Cas9 (5) Cancer (5) Cancer Cell Lines (2) Cancer Metabolism (1) Champalimaud Foundation (1) Computational Biology (2) Copy Number (2) Data-Driven Design (1) DepMap (2) Drug Targets (1) ELLIS Lisbon Unit (1) ELLIS Scholar (1) EMT (1) Epigenetics (1) FCT (1) FCT AI Public Administration (1) FMUL (1) Fulbright (1) Fumarate (1) Functional Genomics (4) GIMM (1) Gene Editing (1) Genomics (1) INESC-ID (1) IPOLFG (1) IST (1) Linear Regression (1) Metabolomics (1) Minimal Library (1) Mode of Action (1) Multi-omics (1) Organoids (1) Pharmacological Screens (1) Polypharmacology (1) Post-doc (1) Precision Medicine (1) Protein Complexes (1) RON (1) Sanger (1) Structural Rearrangements (1) Synthetic Data (1) Synthetic Lethal (1) ULSSM (1) VAE (1) Variational Autoencoders (1) WRN (1) day to day (1)

 Base editing (1)

Base editing screens

 Biomarkers (1)

Cancer Cells CRISPR-Cas9 Large-scale Screens

 Broad (1)

Fulbright Scholarship

 CRISPR (3)

Fulbright Scholarship
Cancer Dependency Map 2.0
Base editing screens

 CRISPR-Cas9 (5)

Efficient large-scale cancer organoid technique
MinLibCas9
Identifying Drug Mode-of-Action with CRISPR-Cas9
Cancer Cells CRISPR-Cas9 Large-scale Screens
Crispy: CRISPR-Cas9 Copy Number Bias

 Cancer (5)

Synthetic lethality in cancer drug discovery challenges and opportunities
Synthetic Cancer Dependency Map
Cancer Dependency Map 2.0
Base editing screens
Copy Number Buffering in Cancer

 Cancer Cell Lines (2)

Cancer Cells CRISPR-Cas9 Large-scale Screens
Crispy: CRISPR-Cas9 Copy Number Bias

 Cancer Metabolism (1)

Oncometabolite Fumarate

 Champalimaud Foundation (1)

New Project SYNTHESIS

 Computational Biology (2)

Synthetic lethality in cancer drug discovery challenges and opportunities
Genome and metabolome

 Copy Number (2)

Crispy: CRISPR-Cas9 Copy Number Bias
Copy Number Buffering in Cancer

 Data-Driven Design (1)

MinLibCas9

 DepMap (2)

Synthetic Cancer Dependency Map
Cancer Dependency Map 2.0

 Drug Targets (1)

Identifying Drug Mode-of-Action with CRISPR-Cas9

 ELLIS Lisbon Unit (1)

ELLIS Scholar

 ELLIS Scholar (1)

ELLIS Scholar

 EMT (1)

Oncometabolite Fumarate

 Epigenetics (1)

Oncometabolite Fumarate

 FCT (1)

New Project SYNTHESIS

 FCT AI Public Administration (1)

New Project SARC-RON-AI

 FMUL (1)

New Project SYNTHESIS

 Fulbright (1)

Fulbright Scholarship

 Fumarate (1)

Oncometabolite Fumarate

 Functional Genomics (4)

Fulbright Scholarship
Cancer Dependency Map 2.0
Base editing screens
Efficient large-scale cancer organoid technique

 GIMM (1)

New Project SYNTHESIS

 Gene Editing (1)

Synthetic lethality in cancer drug discovery challenges and opportunities

 Genomics (1)

Genome and metabolome

 INESC-ID (1)

New Project SARC-RON-AI

 IPOLFG (1)

New Project SARC-RON-AI

 IST (1)

Fulbright Scholarship

 Linear Regression (1)

Copy Number Buffering in Cancer

 Metabolomics (1)

Genome and metabolome

 Minimal Library (1)

MinLibCas9

 Mode of Action (1)

Identifying Drug Mode-of-Action with CRISPR-Cas9

 Multi-omics (1)

A technical review of multi-omics data integration methods from classical statistical to deep generative approaches

 Organoids (1)

Efficient large-scale cancer organoid technique

 Pharmacological Screens (1)

Identifying Drug Mode-of-Action with CRISPR-Cas9

 Polypharmacology (1)

Identifying Drug Mode-of-Action with CRISPR-Cas9

 Post-doc (1)

Sanger Postdoctoral Fellow

 Precision Medicine (1)

Cancer Cells CRISPR-Cas9 Large-scale Screens

 Protein Complexes (1)

Copy Number Buffering in Cancer

 RON (1)

New Project SARC-RON-AI

 Sanger (1)

Sanger Postdoctoral Fellow

 Structural Rearrangements (1)

Crispy: CRISPR-Cas9 Copy Number Bias

 Synthetic Data (1)

Synthetic Cancer Dependency Map

 Synthetic Lethal (1)

Synthetic lethality in cancer drug discovery challenges and opportunities

 ULSSM (1)

New Project SARC-RON-AI

 VAE (1)

Synthetic Cancer Dependency Map

 Variational Autoencoders (1)

A technical review of multi-omics data integration methods from classical statistical to deep generative approaches

 WRN (1)

Cancer Cells CRISPR-Cas9 Large-scale Screens

 day to day (1)

Sanger Postdoctoral Fellow